COEP
COEP
NASDAQ · Biotechnology

Coeptis Therapeutics Holding

$11.27
+0.66 (+6.22%)
As of Feb 8, 2:16 PM ET ·
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 8.74M 7.84M 7.34M
Net Income -2,031,310 -1,359,886 -1,470,733
EPS
Profit Margin -23.2% -17.3% -20.0%
Rev Growth +14.6% -0.2% +5.0%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 13.09M 13.18M 12.69M
Total Equity 46.40M 52.11M 53.17M
D/E Ratio 0.28 0.25 0.24
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA -2,389,064 -2,398,436 -1,921,173
Free Cash Flow -1,186,852 -1,098,506 -895,782